Next in the FPM Conversation Series: “Enabling a Greater Diversity of People in Clinical Trials”

Posted on: Monday 15 February 2021
Author: FPM

The next in ourĀ FPM Conversation Series will take place on 18 March 2021. This online meeting will discuss and debate scientific and social issues surrounding enabling a greater diversity of people in clinical trial programs, and the implications for Pharmaceutical Medicine professionals who design study protocols/programs.

Bringing together an expert panel with extensive experience in pharmaceutical medicine clinical trial program strategy and design, this conversation aims to further explore areas such as genetic PK-PD heterogeneity, appropriate inclusion of ethnically diverse populations and less commonly studied patients & diseases.

Programme and registration